Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine

Morgan, S.H.; Purkiss, P.; Maher, E.R.; Watts, R.W.E.; Curtis, J.R.

doi:10.1042/cs073041Pc

Skip Nav Destination

Article navigation

Conference Abstract| December 01 1987

Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine

S.H. Morgan;

S.H. Morgan

1Clinical Research Centre, Harrow HA1 3UJ, UK

Search for other works by this author on:

This Site

PubMed

Google Scholar

P. Purkiss;

P. Purkiss

1Clinical Research Centre, Harrow HA1 3UJ, UK

Search for other works by this author on:

This Site

PubMed

Google Scholar

E.R. Maher;

E.R. Maher

∗Dept. Medicine, Charing Cross Hospital, London, UK

Search for other works by this author on:

This Site

PubMed

Google Scholar

R.W.E. Watts;

R.W.E. Watts

1Clinical Research Centre, Harrow HA1 3UJ, UK

Search for other works by this author on:

This Site

PubMed

Google Scholar

J.R. Curtis

∗Dept. Medicine, Charing Cross Hospital, London, UK

Search for other works by this author on:

This Site

PubMed

Google Scholar

Author and article information

Publisher: Portland Press Ltd

Online ISSN: 1470-8736

Print ISSN: 0143-5221

1987

Clin Sci (Lond) (1987) 73 (s17): 41P.

https://doi.org/10.1042/cs073041Pc

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795
Portland Press Company no. 02453983

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Biochemical Society Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Oxalate Retention in End-Stage Renal Failure (ESRF): Haemodialysis (HD) vs Chronic Ambulatory Peritoneal Dialysis (CAPD) and the Effects of Ascorbic Acid and Pyridoxine

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only